Moderna, Merck, cancer vaccine, mRNA cancer vaccine, melanoma, Moderna stock, MRNA stock, Keytruda, personalized cancer vaccine, Phase 3 trial, cancer treatment, melanoma vaccine, biotech stocks, Merck stock, cancer research

Can Cancer Finally Be Beaten? Moderna-Merck Vaccine Success Sends Moderna Stock Soaring

Moderna and Merck’s personalized mRNA cancer vaccine, combined with Keytruda, met key goals in a pivotal melanoma study. The clinical result sent Moderna shares sharply…

Vasundhra Tewari

August 19

Zumutor Biologics, cancer therapy, biotech startup, Series B funding, immunotherapy, ZM008, NK cell therapy, oncology, biotech funding, healthcare startup, clinical trials, Accel, Bharat Innovation Fund, Premji Invest, Bengaluru biotech, India biotech sector, cancer treatment, biotechnology, startup funding, life sciences

Zumutor Biologics Raises $7.3 Million to Advance Clinical Trials of Novel Cancer Therapy

Khushi Bhatia

4 min